The in vitro susceptibilities to the novel triazole isavuconazole and six other antifungal agents of a large collection of Rasamsonia isolates (n ‫؍‬ 47) belonging to seven species were determined. Isavuconazole and voriconazole had no in vitro activity (MIC, >32 mg/liter) against isolates of the Rasamsonia argillacea species complex. The echinocandins were the most potent antifungal drugs against all of the isolates tested (minimum effective concentration, <0.19 mg/liter).
cafungin and caspofungin were determined microscopically as the lowest concentrations of the drugs promoting abnormal, short, and branched hyphal clusters (12) . For calculation of the geometric mean (GM), MICs of Ͼ16 mg/liter were set at 32 mg/ liter. A clinical Aspergillus fumigatus isolate and a Candida parapsilosis reference strain (ATCC 22019) recommended by EUCAST were used as controls. Isavuconazole breakpoints are defined for A. fumigatus (Յ1 mg/liter for susceptible, Ͼ1 mg/liter for resistant) by EUCAST version 8.0 (valid from 16 November 2015).
The in vitro susceptibilities (the GM and range of the MIC) of the different Rasamsonia isolates to isavuconazole and the other antifungals are shown in Table 1 . The isavuconazole MICs for all of the isolates in the R. argillacea species complex (R. argillacea, R. aegroticola, R. eburnea, and R. piperina) were high (Ͼ32 mg/liter). Voriconazole had also no activity against isolates in the R. argillacea species complex. The GMs of the MICs of amphotericin B, posaconazole, and itraconazole were variable. The MECs of micafungin and caspofungin for all of the Rasamsonia isolates were low. For R. cyclindrospora and R. brevistipitata, the overall MICs/ MECs of all of the antifungals tested were low.
Here, we show for the first time that the isavuconazole MICs for the emerging pathogenic R. aergillacea species complex in vitro are high, suggesting no meaningful activity.
It was shown that isavuconazole has potent in vitro activity against most common Aspergillus species, Purpureocillium lilacinum (ϭ Paecilomyces lilacinus), and Scedosporium apiospermum (13, 14) . The MICs for fungi of the family Mucoraceae varied between the genera (15) .
The finding that the MICs of voriconazole were high and the MECs of echinocandins were low for R. aergillacea is consistent with a previous report in which susceptibility testing was performed by the broth microdilution method of the CLSI (M38-A2) (2). R. cyclindrospora and R. brevistipitata, both exhibiting low isavuconazole MICs, were mostly isolated from the environment and have so far not been described as pathogens causing invasive fungal infections.
In summary, we found high isavuconazole MICs for isolates of the R. argillacea species complex, indicating that this agent may not be a viable treatment option for invasive infections with this emerging fungus. However, future in vivo studies are warranted to verify the in vitro data obtained in the present study.
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